About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.
Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide ...
As reports surface that the UK’s national screening committee are set to reject proposals for any national prostate screening programme, experts warn that the decision, if followed through with, puts ...
Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...
The UK’s approach to prostate cancer is failing men from pre-diagnosis through to advanced disease management, according to new reports. Experts cite three critical failings: the lack of a screening ...
ABOUT IT. PROSTATE CANCER. IT CAN BE A TOPIC MANY OF US TRY TO AVOID, ESPECIALLY WHEN IT COMES TO HOW YOU HAVE TO SCREEN FOR IT. BUT DURING THIS NATIONAL MEN’S HEALTH AWARENESS MONTH, DOCTORS HAVE A ...
Morning Overview on MSN
New prostate cancer immunotherapy slashes biomarkers by up to 99%
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results